𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Character of growth and differentiation of OC15S1 in syngeneic and allogeneic mice

✍ Scribed by P. A. Dyban


Publisher
Springer US
Year
1984
Tongue
English
Weight
252 KB
Volume
97
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effect of lentinan on tumor growth in mu
✍ József Zákány; Goro Chihara; József Fachet 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 510 KB

## Abstract The effect of lentinan on retardation and regression of transplanted tumors was analysed in allogeneic and syngeneic tumor‐host systems. The effect of lentinan treatment was most variable in random‐bred Swiss albino mice bearing sarcoma 180. With inbred host strains, it was most effecti

Inhibition of syngeneic tumor growth in
✍ Masuo Hosokawa; Masahiro Imamura; Tsuneyuki Oikawa; Eiki Gotohda; Takao Kodama; 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 551 KB

## Abstract The growth of a transplantable tumor (KMT‐17) in syngeneic Wistar King Aptekman/Mk (WKA) rats was inhibited by preimmunization with allogeneic normal cells from Donryu strain rats. The phenomenon is referred to as allogeneic cell immunity. A slight inhibition was observed in rats immuni

Immunological characteristics of leukemi
✍ Masuo Hosokawa; Tetsuro Yamashita; Eiki Gotohda; Noritoshi Takeichi; Takao Kodam 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 666 KB

## Abstract The growth of transplanted tumors was strongly inhibited in syngeneic Wistar King Aptekman (WKA) rats immunized with allogeneic tumor cells from Donryu rats. This phenomenon of non‐specific immunity against tumors is referred to as “allogeneic cell immunity”. However, an exception to th

Accelerated growth of syngeneic tumors i
✍ Patsy H. Lill; J. Milburn Jessup; Margaret L. Kripke 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 435 KB

## Abstract BALB/c and C3H‐ mice were given a single injection of methylcholanthrene (MCA) and were tested at various times thereafter for immunologic reactivity and resistance to syngeneic tumor challenge. MCA treatment did not affect the rejection of H‐2‐incompatible tumor allografts, the rejecti